Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
Novel PSEN1 (Q223 L) mutation causes early-onset Alzheimer’s disease: A case report
Jie Li, Fen-Li Zhou, Juan-Juan Chen, Zhi-Jian Lin, Xin Shi, Guo-Gao Zhang, Li Yi, Jun Hu, Xu-Hui Chen, Department of Neurology, Peking University Shenzhen Hospital, Shenzhen 518000, Guangdong Province, China
Jie Li, Jun Hu, Xu-Hui Chen, Shenzhen Key Laboratory for Neuronal Structural Biology, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen 518036, Guangdong Province, China
Hong-Jie Yang, Meng-Jie Dong, Department of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen 518000, Guangdong Province, China
Co-corresponding authors: Jun Hu and Xu-Hui Chen.
Author contributions: Li J and Chen XH conceptualized and designed the case report, drafted and revised the initial manuscript; Zhou FL, Chen JJ, Lin ZJ, Shi X, and Zhang GG contributed to the supervision, and writing, review and editing of the manuscript; Yi L and Hu J contributed to the conception and design of the manuscript; Yang HJ and Dong MJ performed positron emission computed tomography analysis; Hu J and Chen XH contributed equally to this article, they are the co-corresponding authors of this manuscript; and all authors have reviewed the results and approved the final version of the manuscript.
Supported by Shenzhen Basic Research Program, No. JCYJ20241202124859016.
Informed consent statement: The informed consent form has been signed.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Xu-Hui Chen, MD, PhD, Department of Neurology, Peking University Shenzhen Hospital, Lianhua Road, Shenzhen 518000, Guangdong Province, China.
Received: November 17, 2025
Revised: December 31, 2025
Accepted: May 6, 2026
Published online: June 28, 2026
Processing time: 220 Days and 13.5 Hours
Revised: December 31, 2025
Accepted: May 6, 2026
Published online: June 28, 2026
Processing time: 220 Days and 13.5 Hours
Core Tip
Core Tip: We identified a novel p.Gln223 Leu mutation in PSEN1 in a 43-year-old Chinese female with autosomal dominant early-onset Alzheimer’s disease (EOAD). Comprehensive clinical, neuroimaging, cerebrospinal fluid biomarkers, and 18F-florbetapir/18F-flortaucipir positron emission topography findings confirmed typical Alzheimer’s pathology. This mutation occurs at a mutational hotspot of PSEN1, is predicted to be pathogenic by in silico analysis, and has not been previously reported in public databases. Our report expands the mutation spectrum of PSEN1, enriches genotype - phenotype correlations of familial EOAD, and provides new evidence for the genetic diagnosis, pathogenesis research, and genetic coun